Seizert Capital Partners LLC Buys 6,190 Shares of National Research Co. (NASDAQ:NRC)

Seizert Capital Partners LLC grew its stake in shares of National Research Co. (NASDAQ:NRC) by 53.9% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 17,668 shares of the company’s stock after acquiring an additional 6,190 shares during the quarter. Seizert Capital Partners LLC owned about 0.07% of National Research worth $404,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of NRC. Swiss National Bank lifted its position in shares of National Research by 8.2% during the 1st quarter. Swiss National Bank now owns 31,500 shares of the company’s stock valued at $1,248,000 after acquiring an additional 2,400 shares during the period. Sei Investments Co. raised its holdings in shares of National Research by 45.2% during the 1st quarter. Sei Investments Co. now owns 61,770 shares of the company’s stock worth $2,447,000 after buying an additional 19,217 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in shares of National Research by 6.3% during the 1st quarter. Russell Investments Group Ltd. now owns 14,348 shares of the company’s stock worth $568,000 after buying an additional 847 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of National Research by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 944,995 shares of the company’s stock worth $37,431,000 after buying an additional 10,351 shares in the last quarter. Finally, BOKF NA acquired a new position in shares of National Research during the 1st quarter worth $243,000. 47.26% of the stock is currently owned by institutional investors.

National Research Price Performance

National Research stock opened at $19.14 on Monday. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.37 and a current ratio of 0.47. National Research Co. has a 52 week low of $17.62 and a 52 week high of $42.38. The stock has a market capitalization of $456.87 million, a P/E ratio of 16.94 and a beta of 0.51. The stock has a fifty day moving average of $20.17 and a 200-day moving average of $23.52.

National Research (NASDAQ:NRC) last posted its quarterly earnings results on Friday, October 25th. The company reported $0.24 EPS for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The company had revenue of $35.82 million during the quarter.

National Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be issued a dividend of $0.12 per share. The ex-dividend date is Friday, December 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.51%. National Research’s dividend payout ratio (DPR) is currently 42.48%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.